CN109971669A - The detection method and application of bifidobacterium pseudocatenulatum and Residue of Antibiotics in Milk - Google Patents
The detection method and application of bifidobacterium pseudocatenulatum and Residue of Antibiotics in Milk Download PDFInfo
- Publication number
- CN109971669A CN109971669A CN201910104369.XA CN201910104369A CN109971669A CN 109971669 A CN109971669 A CN 109971669A CN 201910104369 A CN201910104369 A CN 201910104369A CN 109971669 A CN109971669 A CN 109971669A
- Authority
- CN
- China
- Prior art keywords
- milk
- standard
- added
- sample
- antibiotic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013336 milk Nutrition 0.000 title claims abstract description 65
- 239000008267 milk Substances 0.000 title claims abstract description 65
- 210000004080 milk Anatomy 0.000 title claims abstract description 65
- 241001134772 Bifidobacterium pseudocatenulatum Species 0.000 title claims abstract description 30
- 238000001514 detection method Methods 0.000 title claims description 47
- 239000003242 anti bacterial agent Substances 0.000 title claims description 14
- 229940088710 antibiotic agent Drugs 0.000 title claims description 14
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 claims abstract description 88
- 239000004098 Tetracycline Substances 0.000 claims abstract description 46
- 235000019364 tetracycline Nutrition 0.000 claims abstract description 46
- 150000003522 tetracyclines Chemical class 0.000 claims abstract description 46
- 229960002180 tetracycline Drugs 0.000 claims abstract description 45
- 229930101283 tetracycline Natural products 0.000 claims abstract description 45
- 229960003276 erythromycin Drugs 0.000 claims abstract description 44
- 238000000034 method Methods 0.000 claims abstract description 38
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 claims abstract description 23
- 238000012216 screening Methods 0.000 claims abstract description 22
- 229930182555 Penicillin Natural products 0.000 claims abstract description 19
- 229940049954 penicillin Drugs 0.000 claims abstract description 19
- 244000005700 microbiome Species 0.000 claims abstract description 6
- 230000003115 biocidal effect Effects 0.000 claims description 53
- 239000000243 solution Substances 0.000 claims description 31
- 241000894006 Bacteria Species 0.000 claims description 30
- 238000012360 testing method Methods 0.000 claims description 24
- 239000012224 working solution Substances 0.000 claims description 22
- 230000001580 bacterial effect Effects 0.000 claims description 21
- 238000002360 preparation method Methods 0.000 claims description 20
- 230000012010 growth Effects 0.000 claims description 17
- 239000001963 growth medium Substances 0.000 claims description 17
- 238000002835 absorbance Methods 0.000 claims description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 9
- 239000012153 distilled water Substances 0.000 claims description 9
- CEQFOVLGLXCDCX-WUKNDPDISA-N methyl red Chemical compound C1=CC(N(C)C)=CC=C1\N=N\C1=CC=CC=C1C(O)=O CEQFOVLGLXCDCX-WUKNDPDISA-N 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 238000004321 preservation Methods 0.000 claims description 7
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 6
- 239000013641 positive control Substances 0.000 claims description 6
- 239000007787 solid Substances 0.000 claims description 6
- 230000001954 sterilising effect Effects 0.000 claims description 6
- 238000004659 sterilization and disinfection Methods 0.000 claims description 6
- 239000000725 suspension Substances 0.000 claims description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 5
- 239000006071 cream Substances 0.000 claims description 5
- 239000008103 glucose Substances 0.000 claims description 5
- 239000002609 medium Substances 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 238000005057 refrigeration Methods 0.000 claims description 4
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 3
- 239000004201 L-cysteine Substances 0.000 claims description 3
- 235000013878 L-cysteine Nutrition 0.000 claims description 3
- 229920002472 Starch Polymers 0.000 claims description 3
- 239000001110 calcium chloride Substances 0.000 claims description 3
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 3
- 229940041514 candida albicans extract Drugs 0.000 claims description 3
- 108010079058 casein hydrolysate Proteins 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 3
- 229960000935 dehydrated alcohol Drugs 0.000 claims description 3
- AIUDWMLXCFRVDR-UHFFFAOYSA-N dimethyl 2-(3-ethyl-3-methylpentyl)propanedioate Chemical compound CCC(C)(CC)CCC(C(=O)OC)C(=O)OC AIUDWMLXCFRVDR-UHFFFAOYSA-N 0.000 claims description 3
- 229910000396 dipotassium phosphate Inorganic materials 0.000 claims description 3
- 229960004756 ethanol Drugs 0.000 claims description 3
- 235000019441 ethanol Nutrition 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 238000004806 packaging method and process Methods 0.000 claims description 3
- 210000000496 pancreas Anatomy 0.000 claims description 3
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 3
- 229920000053 polysorbate 80 Polymers 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 3
- 239000011780 sodium chloride Substances 0.000 claims description 3
- 239000008107 starch Substances 0.000 claims description 3
- 235000019698 starch Nutrition 0.000 claims description 3
- 238000005303 weighing Methods 0.000 claims description 3
- 239000012138 yeast extract Substances 0.000 claims description 3
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 claims description 3
- 229960001763 zinc sulfate Drugs 0.000 claims description 3
- 229910000368 zinc sulfate Inorganic materials 0.000 claims description 3
- 235000020247 cow milk Nutrition 0.000 claims description 2
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 claims description 2
- 235000019797 dipotassium phosphate Nutrition 0.000 claims description 2
- 230000001376 precipitating effect Effects 0.000 claims description 2
- 235000020122 reconstituted milk Nutrition 0.000 claims description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims 2
- 238000005119 centrifugation Methods 0.000 claims 1
- 229910001629 magnesium chloride Inorganic materials 0.000 claims 1
- 235000013305 food Nutrition 0.000 abstract description 9
- 230000035945 sensitivity Effects 0.000 abstract description 7
- 238000007689 inspection Methods 0.000 abstract description 3
- 238000002845 discoloration Methods 0.000 abstract description 2
- 238000011895 specific detection Methods 0.000 abstract description 2
- 229960000723 ampicillin Drugs 0.000 description 24
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 24
- 238000005259 measurement Methods 0.000 description 8
- 239000013642 negative control Substances 0.000 description 8
- 238000011084 recovery Methods 0.000 description 8
- 150000001875 compounds Chemical class 0.000 description 6
- 238000000855 fermentation Methods 0.000 description 5
- 230000004151 fermentation Effects 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- 241000186000 Bifidobacterium Species 0.000 description 4
- 241000283690 Bos taurus Species 0.000 description 4
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 4
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000012086 standard solution Substances 0.000 description 4
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000011550 stock solution Substances 0.000 description 3
- 150000003952 β-lactams Chemical class 0.000 description 3
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- 241000186012 Bifidobacterium breve Species 0.000 description 2
- 102000016938 Catalase Human genes 0.000 description 2
- 108010053835 Catalase Proteins 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- 229930182566 Gentamicin Natural products 0.000 description 2
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 2
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 2
- 229910002651 NO3 Inorganic materials 0.000 description 2
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 241001052560 Thallis Species 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 230000009604 anaerobic growth Effects 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- 238000005452 bending Methods 0.000 description 2
- 239000003782 beta lactam antibiotic agent Substances 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 238000005660 chlorination reaction Methods 0.000 description 2
- -1 class Substances 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229960002518 gentamicin Drugs 0.000 description 2
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 2
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 2
- 239000003120 macrolide antibiotic agent Substances 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 235000019371 penicillin G benzathine Nutrition 0.000 description 2
- 229940056360 penicillin g Drugs 0.000 description 2
- 239000006041 probiotic Substances 0.000 description 2
- 235000018291 probiotics Nutrition 0.000 description 2
- 230000010076 replication Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 241000304886 Bacilli Species 0.000 description 1
- 208000031462 Bovine Mastitis Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000193385 Geobacillus stearothermophilus Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000194020 Streptococcus thermophilus Species 0.000 description 1
- 208000031320 Teratogenesis Diseases 0.000 description 1
- 108010059993 Vancomycin Proteins 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000011443 conventional therapy Methods 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000013537 high throughput screening Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 150000003951 lactams Chemical class 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- 229940041033 macrolides Drugs 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- IVBHGBMCVLDMKU-GXNBUGAJSA-N piperacillin Chemical compound O=C1C(=O)N(CC)CCN1C(=O)N[C@H](C=1C=CC=CC=1)C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 IVBHGBMCVLDMKU-GXNBUGAJSA-N 0.000 description 1
- 229960002292 piperacillin Drugs 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 229940040944 tetracyclines Drugs 0.000 description 1
- 229960003165 vancomycin Drugs 0.000 description 1
- MYPYJXKWCTUITO-LYRMYLQWSA-N vancomycin Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-N 0.000 description 1
- MYPYJXKWCTUITO-UHFFFAOYSA-N vancomycin Natural products O1C(C(=C2)Cl)=CC=C2C(O)C(C(NC(C2=CC(O)=CC(O)=C2C=2C(O)=CC=C3C=2)C(O)=O)=O)NC(=O)C3NC(=O)C2NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)C(C=C3Cl)=CC=C3OC3=CC2=CC1=C3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1 MYPYJXKWCTUITO-UHFFFAOYSA-N 0.000 description 1
- 239000002132 β-lactam antibiotic Substances 0.000 description 1
- 229940124586 β-lactam antibiotics Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
- C12Q1/06—Quantitative determination
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/18—Testing for antimicrobial activity of a material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Abstract
The invention discloses a kind of bifidobacterium pseudocatenulatum DSQL-1, are preserved in China Committee for Culture Collection of Microorganisms's common micro-organisms center, deposit number CGMCCNo.12067 on 2 18th, 2016.And its application in screening Residues in Milk tetracycline, penicillin and erythromycin is disclosed, and disclose specific detection method.The screening methods of the method for the present invention are easy to operate, can be not required to special precision instrument, judgment method is easy, accurate, and sensitivity and accuracy are high, is suitble to Safety of Food Quality inspection, practical directly by observation indicator color discoloration interpretation result.
Description
Technical field
The invention belongs to more particularly relate to a kind of bifidobacterium pseudocatenulatum in life science and field of food safety
DSQL-1 and the method for quickly detecting Residues in Milk antibiotic using the bacterial strain.
Background technique
Residue of Antibiotics in Milk is a major issue of milk safety.Residue of Antibiotics in Milk not only can be to human body
Various adverse effects are generated, such as cause human body to generate drug resistance, and intestinal bacilli illness, allergic reaction, teratogenesis, mutagenesis occur
Etc. many reactions.In addition, may also suppress lactobacter growth, fermentation is caused to fail, brings economic loss to enterprise, and influence ox
The outlet and trade of milk and Related product.
Antibiotic is widely used in treating and preventing cow disease, unavoidably causes Residue of Antibiotics in Milk.This
Outside, application antibiotic treatment cow disease while obtaining effect, it is lack of standardization use antibiotic, such as increasing dosage,
The extended treatment phase, or even to the behavior of milk cow in lactation period prolonged application antibiotic prophylaxis disease or even the illegal producer fresh
Antibiotic anti-corrosion etc. is added in milk, so that Residue of Antibiotics in Milk is exceeded.
Antibiotics leftover detection is the important measures of milk foods security control and management.China's food hygienic standard at present
Have specified in (GB/T 4789.27-2008) using the detection method of micro-biological process screening Residue of Antibiotics in Milk
TTC method and bacillus stearothermophilus inhibit method.Wherein TTC method equipment is simple, expense is low, is suitble to screening and the base of large sample
Laboratory operation and be widely used, which predominantly detects benzyl penicillin and streptomysin, the gentamicin and card of beta-lactam class
That mycin.In addition, the testing principle and result of National Standard Method judge whether pressed down by residual antibiotic according to the growth of streptococcus thermophilus
System and obtain, due to be added sample after 37 DEG C cultivate 2 hours, under this condition major part environment in bacterium (such as escherichia coli,
The bacterium of the catalase-positives such as staphylococcus epidermis) fast-growth and the color of TTC can be caused to change, in operating process such as
Appearance is polluted, and will lead to and false negative result occurs.
In addition, the national standard method that China uses at present does not include the detection to tetracycline, erythromycin, vancomycin etc..Four
The speed of growth that ring element class antibiotic can prevent and treat infectious disease, improve feed efficiency, accelerate animal, in animal husbandry
To extensive use.In the breeding process of milk cow, tetracycline is commonly used for feed addictive and prevention and treatment milk bovine mastitis, to lead
Cause there may be tetracycline residue in milk.Erythromycin belongs to macrolide antibiotics, is also widely used for poultry, fowl, aquatic products and supports
In growing, field of food safety mainly uses instrumental method to carry out the residual quantity of erythromycin in analyzing animal derived food.
The important method that detection is public health and food safety management is carried out to Residue of Antibiotics in Milk.In face of milk
The substantial increase (Chinese milk crop in 2017 occupies third place in the world, 35.7billion kilograms) of yield, people's lives
Horizontal raising and the demand to the increase of milk and Related product consumption figure and dairy management and milk related industry,
A variety of remaining methods of common antibiotics in simple, quick, the effective detection milk of one kind are established to be of great significance.In milk most
Main antibiotic risk is the once most common beta-lactam antibiotic mesh as caused by intramammary treatment and conventional therapy
It is preceding to be still widely used, but with reasons such as the increases of antibody-resistant bacterium, " non-beta-lactam " drug is used in mastitis treatment
Ratio it is higher and higher, it means that the risk of non-belt-lactam antibiotics residues is also with increasing, therefore, only detect β-
The strategy of lactams is abnormally dangerous, such as common tetracycline medication will be unable to detect correct result.
Antimicrobial method have it is easy to operate, instrument and equipment and personnel requirement be not high, and sample pre-treatments are simple, as a result easily
In observation and interpretation, the features such as detection time is short, it is used for the screening of batch samples always.The present invention mainly utilizes tetracycline
The anaerobic type probiotics strain of the common antibiotics such as class, macrolides, beta-lactam sensitivity is established a kind of based on microorganism
Inhibition method can in Rapid Screening and quantitative detection milk the antibiotic such as tetracycline, erythromycin and penicillin detection method.
Summary of the invention
1, goal of the invention.
The present invention filters out one plant of bifidobacterium pseudocatenulatum bacterium to antibiotic sensitives such as tetracycline, erythromycin, penicillin
Strain, and thus establish one kind and simply, quickly, sensitively carry out Residue of Antibiotics in Milk detection by work bacterial strain of the bacterial strain
Screening and quantitative detecting method.
2, the technical solution adopted in the present invention.
Bifidobacterium pseudocatenulatum DSQL-1 of the invention was deposited in Chinese microorganism strain preservation on 2 18th, 2016
Administration committee's common micro-organisms center is referred to as the (address: Yard 1, BeiChen xi Road, Chaoyang District, Beijing City 3, China CGMCC
Institute of microbiology, the academy of sciences, postcode 100101) preservation, classification naming is bifidobacterium pseudocatenulatum (Bifidobacterium
Pseudocatenulatum), deposit number is CGMCC No.12067.
Bifidobacterium pseudocatenulatum DSQL-1 bacterial strain of the invention has following microbial characteristic:
(1) colonial morphology: colony diameter 1.2- of the bifidobacterium pseudocatenulatum DSQL-1 bacterial strain on TPY solid plate
It is 1.5mm, milky, circle, protrusion, neat in edge, opaque, there is gloss, it is soft, fine and smooth;
(2) thalli morphology: Grain stain positive sporeless bacterium, thallus is in the shape of a rod, has bending or bifurcation, it is seen that short
Catenation has pleomorphism.
(3) physiological and biochemical property: catalase is negative, decomposition glucose, sucrose, maltose, fructose and galactolipin, regardless of fermentation
L-arabinose, xylose, decomposing urea, nitrate reduction do not test negative, indole negative.
(4) cultural characteristic: anaerobic growth is good, aerobic not grow.35 DEG C -37 DEG C of optimum growth temperature, minimum growth temperature
20 DEG C, 45 DEG C of maximum growth temperature of degree;Optimal pH 6.5-7.0, pH are bad lower than 5.5 or higher than 9.0 growths.
Bifidobacterium pseudocatenulatum DSQL-1 of the invention can be applied to simple, quick, sensitive screening Residues in Milk four
Ring element, erythromycin and penicillin.
Specific detection method are as follows:
(1) bacterial strain activates: by above-mentioned bifidobacterium pseudocatenulatum DSQL-1 strain inoculated in TPY solid medium, 37 DEG C
Cultivate 24-48h;
(2) prepared by bacteria suspension: taking the resulting bifidobacterium pseudocatenulatum DSQL-1TPY bacterium colony of step (1), is matched with PBS adjustment
Bacteria suspension processed and adjust to OD600 value be 0.10-0.12,4 DEG C preservation;
(3) detection is used preparation of culture medium: by weight, caseinhydrolysate 10g, pancreas soy peptone 5.0g, sodium chloride
5.0g, glucose 20.0g, yeast extract 2.0g, L-cysteine 0.5g, soluble starch 0.5g, oligofructose 2g, chlorination
Magnesium 0.5g, calcium chloride 0.1g, zinc sulfate 0.2g, K2HPO4 2.0g, Tween-80 1.0ML, distilled water 1000mL, adjust pH to
6.5-6.8, heating are boiled 5 minutes, qualitative filter paper filtering, 115 DEG C high pressure sterilization 15-20 minutes after packaging, 4 DEG C of guarantors of cooling postposition
It deposits, is spare;
(4) 0.2 ‰ methyl red solution preparations: 0.02g methyl red is weighed, is dissolved with 100mL dehydrated alcohol or 95% ethyl alcohol;
(5) prepared by nonreactive milk: weighing nonreactive milk powder, 10% solution is prepared with sterile distilled water;Or matched with distilled water
After making 10% solution, after 121 DEG C of high pressure sterilizations, 4 DEG C are saved backup;
(6) quantitative criterion control is standby: taking tetracycline, erythromycin and penicillin standard reserving solution, prepares antibiosis with nonreactive cream
Plain standard working solution;500 μ g/L of tetracycline, 450 μ g/L, 400 μ g/L, 350 μ g/L, 300 μ g/L, 250 μ g/L, 200 μ g/L,
The standard working solution of the standard working solution of 150 μ g/L, 100 μ g/L, 50 μ g/L, 0 μ g/L;100 μ g/L of erythromycin, 80 μ g/L, 60 μ
The standard working solution of g/L, 40 μ g/L, 20 μ g/L, 10 μ g/L, 0 μ g/L;100 μ g/L of penicillin, 50 μ g/L, 40 μ g/L, 20 μ g/
L,10μg/L,5μg/L,4μg/L,2μg/L,1μg/L,0μg/L;;4 DEG C of refrigerations are spare;
(7) Specification Curve of Increasing: it is different dense to be separately added into step (5) by the detection culture medium 19.5mL for taking step (3) to prepare
The 400 μ L of antibiotic standard working solution of degree, using 0 μ g/L as growth control;The 100 μ L of bacterium solution of step (2) preparation is added after mixing,
37 DEG C after mixing, Anaerobic culturel 6 hours;Only to add culture medium, the not pipe of added with antibiotic (0 μ g/L) standard pipe plus 100 μ LPBS
For zeroing pipe, the absorbance value of each detection pipe under 600nm wavelength is measured, is vertical so that antibiotic concentration value to be added in standard series pipe
Coordinate, absorbance value are abscissa, draw standard curve;
(8) preparation of samples: taking milk sample 10mL in sterile test tube, 80 DEG C water-bath -15 minutes 10 minutes,
5000rpm is centrifuged 5 minutes, abandons precipitating;Fresh cow milk after other are processed etc. can direct sample;
(9) control of screening positive control is standby: taking tetracycline, erythromycin and penicillin standard reserving solution, is prepared with nonreactive cream
1MRL antibiotic standard pipe: 100 μ g/L of tetracycline;40 μ g/L of erythromycin;4 μ g/L of penicillin;4 DEG C of refrigerations are spare;
(10) sample screening detects: taking the resulting 200 μ L of sample of step (8), is added to the resulting detection culture of step (3)
1.3mL in base, is added the bacterium solution 100 μ L of step (2) preparation, and 37 DEG C, Anaerobic culturel 6 hours;It takes out and step (4) preparation is added
0.02% methyl red indicator, 90 μ L observes result;With added with final concentration of 100 μ g/L tetracycline standard items milk sample, 40
The milk sample of μ g/L erythromycin standard items, 4 μ g/L penicillin standard items milk sample be Rapid Screening positive control instruction
Pipe, using 0 μ g/L as growth control;
(11) sample amounts detect: taking the resulting 400 μ L of sample of step (8), be added to the resulting detection culture of step (4)
Base 19.5mL, is added the bacterium solution 100 μ L of step (2) preparation, and 37 DEG C, Anaerobic culturel 8-10 hours;With only plus culture medium, be not added it is anti-
The pipe of raw element (0 μ g/L) standard pipe plus 100 μ LPBS are zeroing pipe, measure 600nm wavelength absorbance value, read from standard curve
Take residual antibiotic value.
Milk sample of the present invention includes: lactogenesis, liquid milk, reconstituted milk.
Ampicillin standard curve of the present invention is obtained by following methods: utilizing ampicillin stock solution
The standard working solution that compound concentration is respectively, using 0 μ g/L as negative control.Take the ampicillin standard working solution of each concentration
400 μ L are added in the quantitative detection culture medium of 19.5mL and mix, and add detection bacterium solution 100 μ L, 37 DEG C of Anaerobic culturel 6-8h,
The absorbance value for measuring each Concentration Testing pipe under 600nm wavelength, using antibiotic concentration value as ordinate, absorbance value is horizontal seat
Mark draws standard curve.Obtaining standard curve regression equation is that (Y: ampicillin is dense in sample by Y=-0.006X+0.5713
Spend μ g/L, X: the OD600 value of reaction tube), the range of linearity is 1-80 μ g/L, R2It is 0.9943.
Tetracycline standard curve of the present invention is obtained by following methods: utilizing tetracycline stock solution compound concentration
The tetracycline standard work of respectively 50 μ g/L, 100 μ g/L, 150 μ g/L, 200 μ g/L, 250 μ g/L, 300 μ g/L, 350 μ g/L
Liquid, using 0 μ g/L as negative control.Method is the same, and obtaining standard curve regression equation is Y=-1.1574X+0.5362 (Y: sample
Middle tetracycline concentration μ g/L, X: the OD600 value of reaction tube), the range of linearity is 50-350 μ g/L, R2It is 0.9947.
Erythromycin standard curve of the present invention is obtained by following methods: utilizing erythromycin stock solution compound concentration
The standard working solution of respectively 100 μ g/L, 80 μ g/L, 60 μ g/L, 40 μ g/L, 20 μ g/L, 10 μ g/L are negative right with 0 μ g/L
According to.Method is the same, obtain standard curve regression equation be Y=0.00604X+0.5545 (Y: erythromycin concentration μ g/L in sample,
X: the OD600 value of reaction tube), the range of linearity is 10-100 μ g/L, R2It is 0.99977.
The Monitoring lower-cut that the present invention uses is obtained by following methods: compound concentration is 0 μ g/L, 0.25 μ g/L, 0.5 μ g/
L, the ampicillin standard solution of 1 μ g/L, 2 μ g/L, 4 μ g/L, 5 μ g/L, 10 μ g/L;Compound concentration be 5 μ g/L, 10 μ g/L,
The tetracycline titer of 25 μ g/L, 50 μ g/L, 100 μ g/L, compound concentration are 5 μ g/L, 10 μ g/L, 20 μ g/L, 40 μ g/L, 80 μ
The erythromycin titer of g/L, using 0 μ g/L as negative control.The 400 μ L of ampicillin standard working solution of each concentration is taken to be added
It is mixed into the quantitative detection culture medium of 19.5mL, adds detection bacterium solution 100 μ L, 37 DEG C of Anaerobic culturel 6-8h, measure 600nm
The absorbance value of each Concentration Testing pipe under wavelength, to generate the Cmin of bacteriostasis as minimum detection limit.Quantitative detection
Lowest detection is limited to 4 μ g/L of ampicillin, 80 μ g/L of tetracycline, 40 μ g/L of erythromycin.
The rate of recovery of the method for the present invention is added various concentration antibiotic standard solution into known milk sample, repeats
Analysis 3 times, obtained average recovery rate are ampicillin 98.2%, erythromycin 72.49%, tetracycline 106.7%.
The method of the present invention detects the accuracy rate of known mark-on tetracycline sample from 100%, mark-on ampicillin erythromycin
Positive sample (be greater than or equal to MRL) and the accuracy rate of negative sample (lower than MRL) are 90% (36/40), false negative rate 0,
False positive rate 20%.
3, technical effect caused by the present invention.
(1) bifidobacterium pseudocatenulatum DSQL-1 bacterial strain of the present invention has the following characteristics that erythromycin, Piperacillin, Fourth Ring
Element, benzyl penicillin, to sensitivities such as ampicillins;Obligate anaerobic is not easy to be bacterial contamination in incubation;Strain stability is good, easily
In preservation and operation;Compared with bifidobacterium breve (Bifidobacterium breve) DSQH-1 for being all probiotics, to Fourth Ring
The detection accuracy rate of element is higher, more preferable to the sensitivity of erythromycin, and bacterial strain not will cause laboratory to human body and environmental-friendly
And environmental pollution.
(2) principle of the method for the present invention is that have to inhibit to make to bifidobacterium pseudocatenulatum DSQL-1 bacterial strain based on antibiotic
With using this characteristic, by bifidobacterium pseudocatenulatum DSQL-1 bacterial strain to sample progress fermentation process, tracking fermentation process and basis
Fermenting characteristic comes in judgement sample with the presence or absence of antibiotic residue.
(3) screening methods of the method for the present invention are easy to operate, can directly pass through the solidification of observation culture medium or indicator discoloration
Interpretation result, judgment method is easy, accurate, is suitble to Safety of Food Quality inspection, practical.
(4) quantitative detecting method of the method for the present invention is simple and easy to do, is not required to special precision instrument, sensitivity and accuracy
Height is all larger than 95% to the rate of recovery of ampicillin and tetracycline, and the coefficient of variation is respectively less than 10%, meets antibiotic in milk
Remain the accuracy and precision requirement of screening.
Detailed description of the invention
Fig. 1 is Bifidobacterium DSQL-1 to penicillin mark-on sample detection result figure.
Fig. 2 is Bifidobacterium DSQL-1 to erythromycin mark-on sample detection result figure.
Fig. 3 is Bifidobacterium DSQL-1 to tetracycline mark-on sample detection result figure.
Fig. 4 is ampicillin standard curve.
Fig. 5 is tetracycline standard curve.
Fig. 6 is erythromycin standard curve.
Specific embodiment
It is noted that detailed description below is all exemplary property, it is intended to provide further instruction to the present invention.Unless
It is otherwise noted, all scientific and technical terms used herein have normally understood with the technical field of the invention personnel
Identical meanings.
The present invention will be further described combined with specific embodiments below, but illustrated embodiment is not as to limit of the invention
It is fixed.If specializing, the conventional means that technological means used in embodiment is well known to those skilled in the art.
The separation and identification of 1 bifidobacterium pseudocatenulatum bacterial strain of embodiment
Using the excrement of Zhejiang Province health young man as separation sample, 1g excrement is suspended with 10mL PBS and does 10 times of multiple proportions
After dilution, it is inoculated in TPY solid medium, 37 DEG C, Anaerobic culturel 48 hours obtain Bifidobacterium DSQL- of the present invention
1, it is identified as bifidobacterium pseudocatenulatum (Bifidobacterium pseudocatenulatum), on 2 18th, 2016
It is deposited in China Committee for Culture Collection of Microorganisms's common micro-organisms center (address: BeiChen West Road, Chaoyang District, BeiJing City 1
Institute 3, Institute of Microorganism, Academia Sinica, postcode 100101), deposit number is CGMCC No.12067.
TPY agar medium, TPY fluid nutrient medium are Qingdao GaoKeYuan Hai Bo Bioisystech Co., Ltd product.
Bifidobacterium pseudocatenulatum DSQL-1 bacterial strain of the invention has following microbial characteristic:
(1) colonial morphology: colony diameter 1.2- of the bifidobacterium pseudocatenulatum DSQL-1 bacterial strain on TPY solid plate
It is 1.5mm, milky, circle, protrusion, neat in edge, opaque, there is gloss, it is soft, fine and smooth;
(2) thalli morphology: Grain stain positive sporeless bacterium, thallus are in rod shape, and one or both ends are expanded, and have bending
Or bifurcation, form distinctive " Y ", " V " shape structure.
(3) physiological and biochemical property: catalase is negative, decomposition glucose, sucrose, maltose, fructose and galactolipin, regardless of fermentation
L-arabinose, xylose, decomposing urea, nitrate reduction do not test negative, indole negative.
(4) cultural characteristic: anaerobic growth is good, aerobic not grow.35 DEG C -37 DEG C of optimum growth temperature, minimum growth temperature
25 DEG C, 45 DEG C of maximum growth temperature of degree;Optimal pH 6.5-7.0, pH are bad lower than 6.5 or higher than 8.5 growths.
(5)) sensitivity tests of bifidobacterium pseudocatenulatum DSQL-1 strains of the invention: scraps of paper agar is used
(K-B) method of diffusion, chooses the different antibiotic scraps of paper, is test bacterium with bifidobacterium pseudocatenulatum DSQL-1 bacterial strain of the present invention, uses
TPY Agar Plating is set 37 DEG C, Anaerobic culturel 24 hours and is observed, measures different antibiotic to the antibacterial of DSQL-1 bacterial strain
Performance.3 repetitions are done in above-mentioned test, referring to CLSI standard determination.
Sensitivity tests result of the table 1DSQL-1 bacterial strain to different antibiotic
Experimental result: bifidobacterium pseudocatenulatum DSQL-1 bacterial strain of the present invention is to ampicillin, tetracycline, erythromycin, through the ages
Mycin, chloramphenicol, gentamicin are sensitive, can be used as the work bacterial strain of multiple antibiotic residues in high-throughput screening milk.
Embodiment 2: the detection of antibiotic residue in milk sample
(1) bacterial strain activates: bifidobacterium pseudocatenulatum DSQL-1 strain inoculated described in claim 1 is trained in TPY solid
Support base, 37 DEG C of culture 24-48h;
(2) prepared by bacteria suspension: taking the resulting bifidobacterium pseudocatenulatum DSQL-1TPY bacterium colony of step (1), is matched with PBS adjustment
Bacteria suspension processed and adjust to OD600nm value be 0.10-0.12,4 DEG C preservation;
(3) detection is used preparation of culture medium: by weight, caseinhydrolysate 10g, pancreas soy peptone 5.0g, sodium chloride
5.0g, glucose 20.0g, yeast extract 2.0g, L-cysteine 0.5g, soluble starch 0.5g, oligofructose 2g, chlorination
Magnesium 0.5g, calcium chloride 0.1g, zinc sulfate 0.2g, K2HPO42.0g, Tween-80 1.0ML, distilled water 1000mL, adjust pH to
6.5-6.8, heating are boiled 5 minutes, qualitative filter paper filtering, 115 DEG C high pressure sterilization 15-20 minutes after packaging, 4 DEG C of guarantors of cooling postposition
It deposits, is spare;
(4) 0.2 ‰ methyl red solution preparations: 0.02g methyl red is weighed, is dissolved with 100mL dehydrated alcohol or 95% ethyl alcohol;
(5) prepared by nonreactive milk: weighing nonreactive milk powder, 10% solution is prepared with sterile distilled water;Or matched with distilled water
After making 10% solution, after 121 DEG C of high pressure sterilizations, 4 DEG C are saved backup;
(6) standard regulation is standby: taking tetracycline, penicillin and erythromycin standard reserving solution, is released with nonreactive cream and be configured to difference
Concentration antibiotic standard working solution (350 μ g/L of tetracycline, 300 μ g/L, 250 μ g/L, 200 μ g/L, 150 μ g/L, 100 μ g/L,
The standard working solution of 50 μ g/L, 0 μ g/L;100 μ g/L of erythromycin, 80 μ g/L, 60 μ g/L, 40 μ g/L, 20 μ g/L, 10 μ g/L, 0 μ
The standard working solution of g/L;80 μ g/L of ampicillin, 50 μ g/L, 40 μ g/L, 20 μ g/L, 10 μ g/L, 5 μ g/L, 4 μ g/L, 2 μ g/
L, the standard working solution of 1 μ g/L, 0 μ g/L);
(7) Specification Curve of Increasing: it is different dense to be separately added into step (5) by the detection culture medium 1.3mL for taking step (3) to prepare
The 200 μ L of antibiotic standard working solution of degree, using 0 μ g/L as growth control;The 30 μ L of bacterium solution of step (2) preparation is added after mixing,
37 DEG C after mixing, Anaerobic culturel 6 hours;Using not added with antibiotic, the standard pipe that bacterium solution is not added as blank control pipe, 600nm is measured
The absorbance value of each detection pipe under wavelength, antibiotic concentration value to be added in standard series pipe as ordinate, absorbance value is cross
Coordinate draws standard curve;
(8) preparation of samples: taking sample 10mL in sterile test tube, 85 DEG C water-bath 10-15 minutes;5000rpm is centrifuged 5 points
Clock;
(9) sample screening detects: taking the resulting 200 μ L of sample of step (8), is added to the resulting 1.3ml detection of step (3)
In culture medium, the 30 μ L of bacterium solution that step (2) are prepared is added, 37 DEG C, Anaerobic culturel 6 hours take out and step (4) preparation are added
0.02% methyl red indicator, 90 μ L observes result;With the penicillin standard of 100 μ g/L tetracyclines, 40 μ g/L erythromycin, 4 μ g/L
Product solution standard solution is Rapid Screening positive control pipe instruction pipe, using 0 μ g/L as growth control;
(10) sample amounts detect: taking the resulting 400 μ L of sample of step (8), be added to the resulting detection culture of step (4)
Base 19.5mL, is added the bacterium solution 100 μ L of step (2) preparation, and 37 DEG C, Anaerobic culturel 8-10 hours;The blank tube of bacterium solution is not added
Zeroing measures 600nm wavelength absorbance value, and residual antibiotic value is read from standard curve.
Test 1: the determination of limit is detected
Respectively with having added various concentration antibiotic standard items (0 μ g/L of tetracycline, 10 μ g/L, 20 μ g/L, 50 μ g/L, 60 μ g/
L, 70 μ g/L, 80 μ g/L, 90 μ g/L, 100 μ g/L, 200 μ g/L, 400 μ g/L, erythromycin 0,5 μ g/L, 10 μ g/L, 20 μ g/L, 30
μg/L,40μg/L,60μg/L,80μg/L,160μg/L,320μg/L;0 μ g/L of ampicillin, 0.5 μ g/L, 1 μ g/L, 2 μ g/
L,3μg/L,4μg/L,5μg/L,10μg/L,20μg/L,50μg/L,100μg/L;) milk as sample to be tested, carry out sample
Detection.As shown in Figure 1-3, analysis detection is as a result, determine that the lowest detection of the quantitative detection of detection method is limited to ammonia benzyl
4 μ g/L of penicillin, 80 μ g/L of tetracycline, 40 μ g/L of erythromycin.
Test 2:
False negative rate test
Take standard nonreactive milk sample 10mL, antibiotic titer be added, make antibiotic concentration 1.5MRL in milk,
1MRL, 0.5MRL and 0MRL, 10 samples of each concentration, for measuring method with embodiment 2, replication 3 times, be the positive with 1MRL
Control, 0MRL are negative control, to observe the probability of negative findings appearance, calculate false negative rate.
Ampicillin false negative rate is 0 in test result milk;Tetracycline false negative rate is 0;Erythromycin false negative rate
It is 0.
Test 3: false positive rate test
Take standard nonreactive milk sample 10mL, antibiotic titer be added, make antibiotic concentration 1MRL in milk,
0.75MRL, 0.5MRL, 0.25MRL and 0MRL, 10 samples of each concentration, measuring method is with embodiment 2, and replication 3 times,
It is negative control by positive control, 0MRL of 1MRL, the probability that observation positive findings occur calculates false negative rate.
Tetracycline is that false positive rate is 0;Erythromycin 0.75MRL false positive rate is 20% (6/30);Ampicillin
0.75MRL false positive rate is 26.7% (8/30), and 0.5MRL false positive rate is 6.67% (2/30.
Test 4:
Determination of recovery rates
Antibiotic standard items are added in milk sample with various concentration, it is measured by above 2 step of case study on implementation and contains
Amount, every a sample is 3 parts parallel, measurement result such as table 2-4, and the average recovery rate of each antibiotic is tetracycline 106.7%, erythromycin
72.49%, ampicillin 98.2%.
The measurement of the 2 tetracycline standard items rate of recovery of table
The measurement of the 3 erythromycin standard items rate of recovery of table
The measurement of the 4 ampicillin standard items rate of recovery of table
Test 5: milk sample antibiotic residue Screen test
By antibiotic (25 μ g/L of tetracycline, 50 μ g/L, 100 μ g/L, 200 μ g/L, 10 μ g/ of erythromycin containing various concentration
L, 25 μ g/L, 50 μ g/L, 100 μ g/L, 40 μ g/L of ampicillin, 20 μ g/L, 10 μ g/L, 5 μ g/L, 4 μ g/L, 2 μ g/L, 1 μ g/
L,0.5μg/L,0μg/L;) standard solution milk as sample to be tested (using 0 μ g/L as negative control), be added in equal volume
In the resulting screening detection pipe of step (4), addition step (2) resulting bacterium solution, 37 DEG C, Anaerobic culturel 6-8 hours;Instruction is added
Agent occurs red being that antibiotic residue is lower than national standard, is that antibiotic residue is exceeded in yellow.Screening method starts yellow occur
Minimum concentration be 60 μ g/L of tetracycline, 20 μ g/L of erythromycin, 3 μ g/L of ampicillin, determine yellow concentration be tetracycline
80 μ g/L, 40 μ g/L of erythromycin, 4 μ g/L of ampicillin.Highest in Screen test result and the animal food of China's approval
Residue limits (milk: 4 μ g/L of ampicillin, 40 μ g/L of erythromycin, 100 μ g/L of tetracycline) meet or quite, can meet big
Measure the screening of sample.
Test 5: antibiotic residue quantitative detection in milk sample
To contain various concentration standard antibiotic (350 μ g/L of tetracycline, 300 μ g/L, 250 μ g/L, 200 μ g/L, 150 μ g/L,
The standard working solution of 100 μ g/L, 50 μ g/L;100 μ g/L of erythromycin, 80 μ g/L, 60 μ g/L, 40 μ g/L, 20 μ g/L, 10 μ g/L
Standard working solution;80 μ g/L of ampicillin, 50 μ g/L, 40 μ g/L, 20 μ g/L, 10 μ g/L, 5 μ g/L, 4 μ g/L, 2 μ g/L, 1 μ
The standard working solution of g/L;) milk as sample to be tested (using 0 μ g/L as negative control), be added to step (4) resulting inspection
In test tube, be added step (2) resulting bacterium solution, 40 DEG C Anaerobic culturel 12-16 hours;It is returned to zero with culture medium plus antibiotic-free milk, measurement
The OD600nm of sample cell negative control pipe reads antibiotic concentration value (μ g/L) from standard curve.Measure result such as Fig. 4-6
And shown in table 5-7.
The measurement of 5 ampicillin standard items repeatability of table
The measurement of 6 tetracycline standard items repeatability of table
The measurement of 7 erythromycin standard items repeatability of table
Claims (4)
1. a kind of bifidobacterium pseudocatenulatum DSQL-1 was preserved in Chinese microorganism strain preservation management committee on 2 18th, 2016
Member's meeting common micro-organisms center, deposit number CGMCCNo.12067.
2. bifidobacterium pseudocatenulatum DSQL-1 described in claim 1 is in screening Residues in Milk tetracycline, penicillin and red mould
Application in element.
3. a kind of detection method of Residue of Antibiotics in Milk, which is characterized in that the described method comprises the following steps:
(1) bacterial strain activates: by bifidobacterium pseudocatenulatum DSQL-1 strain inoculated described in claim 1 in TPY solid medium,
37 DEG C of culture 24-48h;
(2) prepared by bacteria suspension: taking the resulting bifidobacterium pseudocatenulatum DSQL-1TPY bacterium colony of step (1), is adjusted with PBS and prepare bacterium
Suspension and adjust to OD600 value be 0.10-0.12,4 DEG C preservation;
(3) detection is used preparation of culture medium: by weight, caseinhydrolysate 10g, pancreas soy peptone 5.0g, sodium chloride 5.0g,
Glucose 20.0g, yeast extract 2.0g, L-cysteine 0.5g, soluble starch 0.5g, oligofructose 2g, magnesium chloride
0.5g, calcium chloride 0.1g, zinc sulfate 0.2g, K2HPO4 2.0g, Tween-80 1.0ML, distilled water 1000mL, adjust pH to
6.5-6.8, heating are boiled 5 minutes, qualitative filter paper filtering, 115 DEG C high pressure sterilization 15-20 minutes after packaging, 4 DEG C of guarantors of cooling postposition
It deposits, is spare;
(4) 0.2 ‰ methyl red solution preparations: 0.02g methyl red is weighed, is dissolved with 100mL dehydrated alcohol or 95% ethyl alcohol;
(5) prepared by nonreactive milk: weighing nonreactive milk powder, 10% solution is prepared with sterile distilled water;Or it is prepared with distilled water
After 10% solution, after 121 DEG C of high pressure sterilizations, 4 DEG C are saved backup;
(6) quantitative criterion control is standby: taking tetracycline, erythromycin and penicillin standard reserving solution, prepares antibiotic mark with nonreactive cream
Quasi- working solution;500 μ g/L of tetracycline, 450 μ g/L, 400 μ g/L, 350 μ g/L, 300 μ g/L, 250 μ g/L, 200 μ g/L, 150 μ g/
L, the standard working solution of the standard working solution of 100 μ g/L, 50 μ g/L, 0 μ g/L;100 μ g/L of erythromycin, 80 μ g/L, 60 μ g/L, 40
The standard working solution of μ g/L, 20 μ g/L, 10 μ g/L, 0 μ g/L;100 μ g/L of penicillin, 50 μ g/L, 40 μ g/L, 20 μ g/L, 10 μ g/
L,5μg/L,4μg/L,2μg/L,1μg/L,0μg/L;;4 DEG C of refrigerations are spare;
(7) Specification Curve of Increasing: the detection culture medium 19.5mL for taking step (3) to prepare is separately added into step (5) various concentration
400 μ L of antibiotic standard working solution, using 0 μ g/L as growth control;The 100 μ L of bacterium solution of step (2) preparation is added after mixing, mixes
37 DEG C afterwards, Anaerobic culturel 6 hours;Only to add, culture medium, the pipe of added with antibiotic (0 μ g/L) standard pipe plus 100 μ LPBS are not to adjust
Zero pipe, measures the absorbance value of each detection pipe under 600nm wavelength, is vertical sit so that antibiotic concentration value to be added in standard series pipe
Mark, absorbance value is abscissa, draws standard curve;
(8) preparation of samples: taking milk sample 10mL in sterile test tube, 80 DEG C water-bath -15 minutes 10 minutes, 5000rpm
Precipitating is abandoned in centrifugation 5 minutes;Fresh cow milk after other are processed etc. can direct sample;
(9) control of screening positive control is standby: taking tetracycline, erythromycin and penicillin standard reserving solution, prepares 1MRL with nonreactive cream
Antibiotic standard pipe: 100 μ g/L of tetracycline;40 μ g/L of erythromycin;4 μ g/L of penicillin;4 DEG C of refrigerations are spare;
(10) sample screening detects: taking the resulting 200 μ L of sample of step (8), is added in the resulting detection culture medium of step (3)
1.3mL, is added the bacterium solution 100 μ L of step (2) preparation, and 37 DEG C, Anaerobic culturel 6 hours;It takes out and step (4) preparation is added
0.02% methyl red indicator, 90 μ L observes result;With added with final concentration of 100 μ g/L tetracycline standard items milk sample, 40
The milk sample of μ g/L erythromycin standard items, 4 μ g/L penicillin standard items milk sample be Rapid Screening positive control instruction
Pipe, using 0 μ g/L as growth control;
(11) sample amounts detect: taking the resulting 400 μ L of sample of step (8), be added to the resulting detection culture medium of step (4)
19.5mL, is added the bacterium solution 100 μ L of step (2) preparation, and 37 DEG C, Anaerobic culturel 8-10 hours;Only to add culture medium, antibiosis be not added
The pipe of 0 μ g/L standard pipe of element plus 100 μ LPBS are zeroing pipe, measure 600nm wavelength absorbance value, read from standard curve
Residual antibiotic value.
4. the detection method of Residue of Antibiotics in Milk according to claim 3, it is characterised in that: the milk sample
For lactogenesis, liquid milk or reconstituted milk.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910104369.XA CN109971669A (en) | 2019-02-01 | 2019-02-01 | The detection method and application of bifidobacterium pseudocatenulatum and Residue of Antibiotics in Milk |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910104369.XA CN109971669A (en) | 2019-02-01 | 2019-02-01 | The detection method and application of bifidobacterium pseudocatenulatum and Residue of Antibiotics in Milk |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109971669A true CN109971669A (en) | 2019-07-05 |
Family
ID=67076855
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910104369.XA Pending CN109971669A (en) | 2019-02-01 | 2019-02-01 | The detection method and application of bifidobacterium pseudocatenulatum and Residue of Antibiotics in Milk |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109971669A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114058671A (en) * | 2020-07-31 | 2022-02-18 | 北京安普生化科技有限公司 | Klebsiella pneumoniae detection method and detection reagent device for producing ethanol |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102590196A (en) * | 2012-01-06 | 2012-07-18 | 温州医学院 | Test method for rapidly screening antibacterial residue in animal food samples |
CN105713859A (en) * | 2016-03-02 | 2016-06-29 | 温州医科大学 | Bifidobacterium breve and method for detecting various antibiotic residues in milk and application |
-
2019
- 2019-02-01 CN CN201910104369.XA patent/CN109971669A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102590196A (en) * | 2012-01-06 | 2012-07-18 | 温州医学院 | Test method for rapidly screening antibacterial residue in animal food samples |
CN105713859A (en) * | 2016-03-02 | 2016-06-29 | 温州医科大学 | Bifidobacterium breve and method for detecting various antibiotic residues in milk and application |
Non-Patent Citations (5)
Title |
---|
J. MÄTTӦ, ET AL.: "Comparison of three test media for antimicrobial susceptibility testing of bifidobacteria using the Etest method", 《INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS》 * |
S. DELGADO, ET AL.: "In vitro evaluation of the probiotic properties of human intestinal Bifidobacterium species and selection of new probiotic candidates", 《JOURNAL OF APPLIED MICROBIOLOGY》 * |
SUSANA DELGADO, ET AL.: "Antibiotic Susceptibility of Lactobacillus and Bifidobacterium Species from the Human Gastrointestinal Tract", 《CURRENT MICROBIOLOGY》 * |
周彦宏等: "婴儿肠道菌群中乳酸菌的分离鉴定及其多样性分析", 《食品工业科技》 * |
马乐好等主编: "《微生物培养基实用手册》", 31 March 2006, 吉林科学技术出版社 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114058671A (en) * | 2020-07-31 | 2022-02-18 | 北京安普生化科技有限公司 | Klebsiella pneumoniae detection method and detection reagent device for producing ethanol |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Wesley Catlin | Nutritional profiles of Neisseria gonorrhoeae, Neisseria meningitidis, and Neisseria lactamica in chemically defined media and the use of growth requirements for gonococcal typing | |
AU609794B2 (en) | A test set and a process for the determination of antibiotics in milk and a novel streptococcus thermophilus strain to be used therein | |
Domig et al. | Methods used for the isolation, enumeration, characterisation and identification of Enterococcus spp.: 1. Media for isolation and enumeration | |
CN101570782B (en) | Detection kit and detection method for 8 species of pathogenic bacteria in dairy products | |
CN101412977B (en) | Culture medium for composite enrichment of salmonella, Vibrio parahaemolyticus and Vibrio cholerae, and preparation thereof | |
JPH07505788A (en) | Unit for detection of residues of antibacterial compounds in liquids | |
Blood et al. | Media for ‘total’Enterobacteriaceae, coliforms and Escherichia coli | |
CN101412978A (en) | Culture medium for composite enrichment of salmonella, Listeria monocytogenes and Staphylococcus aureus, and preparation thereof | |
DK153333B (en) | PROCEDURE FOR PREPARING A UNIT FOR DETERMINING ANTIBIOTICS AND SULPHONAMID RESIDUES IN BIOLOGICAL LIQUIDS AND UNITS PREPARED BY THE PROCEDURE | |
Solomon et al. | Rapid diagnosis of Brucella melitensis in blood: some operational characteristics of the BACT/ALERT | |
CN105713859A (en) | Bifidobacterium breve and method for detecting various antibiotic residues in milk and application | |
Al Humam | Special biochemical profiles of Escherichia coli strains isolated from humans and camels by the VITEK 2 automated system in Al-Ahsa, Saudi Arabia | |
CN102590196B (en) | The detection method of antibacterial medicine residue in a kind of Rapid Screening animal foodstuff sample | |
CN109971669A (en) | The detection method and application of bifidobacterium pseudocatenulatum and Residue of Antibiotics in Milk | |
Sornplang et al. | Antibiotic resistance of lactic acid bacteria isolated from a fermented fish product, Pla-chom | |
Okelo et al. | Improvements in reduction of feed contamination: an alternative monitor of bacterial killing during feed extrusion | |
CN114164157B (en) | Lactobacillus salivarius strain ZK-88 for inhibiting inflammation, relieving swelling and aching of gum, and improving oral flora balance | |
CN116875478A (en) | Animal bifidobacterium subspecies lactis King31 for deodorizing dogs and cats as well as microbial inoculum, preparation method and application | |
NIROOMAND et al. | EFFECT OF OXYGEN REDUCING MEMBRANE FRAGMENTS ON GROWTH OF CAMPYLOBACTER SPP. 1 | |
CN115873081A (en) | Lactein and application thereof in prevention and control of bacterial infection of pets | |
Ball | Microbiological methods for the determination of the B-group vitamins | |
BROVKO et al. | Quantitative assessment of bacterial contamination of raw milk using bioluminescence | |
CN109971670A (en) | The detection method and application of enterococcus faecalis, its culture medium and Residue of Antibiotics in Milk | |
JP5397991B2 (en) | Determination method of vitamin B12 using lactic acid bacteria | |
US20200270670A1 (en) | Culture medium for selectively isolating bacteria of genus clostridium |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Ye Sheng Inventor after: Du Jimei Inventor after: Lou Yongliang Inventor after: Liu Jiaming Inventor before: Du Jimei Inventor before: Liu Jiaming Inventor before: Lou Yongliang Inventor before: Ye Sheng |
|
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190705 |